A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine
Titel:
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine
Auteur:
Munjal, Sagar Brand-Schieber, Elimor Allenby, Kent Spierings, Egilius L.H. Cady, Roger K. Rapoport, Alan M.